Pregabalin (Lyrica) test

Pregabalin (Lyrica) urine test

For urinary screening of Pregabalin, better known under its trade name, Lyrica. Fast, reliable and ISO 13485 certified.

NCE-PGB-1S
Urine
NarcoCheck®
Excellent (≈99%)
5 minutes
500 ng/ml
3 to 5 days after the last intake
Quantity Unit price
From 1 to 4 tests $6.90 per test
From 5 to 9 tests $6.50 per test
From 10 to 19 tests $5.90 per test
From 20 to 30 tests $4.90 per test
More than 30 tests Contact us
In stock
- +

Total: $6.90

Description

The NarcoCheck® PGB rapid test strip is an immunoassay for fast the detection of pregabalin (Lyrica) use in human urine.

Pregabalin is the active substance of Lyrica, a drug used to treat neuropathic pain, epilepsy or generalized anxiety disorders.

After treatment with pregabalin, withdrawal symptoms can be observed, which is why it is necessary to gradually reduce the doses at the end of treatment, but also to check with this urine test that the person has well ceased all consumption.

Pregabalin can also be used as a "recreational" drug because it causes effects close to drunkenness, or even hallucinations.

The consumption of Lyrica can be detected using this pregabalin test for a period of 3 to 5 days (depending on the doses consumed) after the last intake.

Cut-off Details

NarcoCheck - Pregabalin (Lyrica) urine test
Click to see the details

Compound Cut-off (ng/ml)
Gabapentin >20 000
Pregabalin 50
Delivery   United States
We ship worldwide !

Fast and Easy

Description of the test device
Dipping the test
Result: negative
Result: positive
NarcoCheck: professional drug tests

Delivery

Similar or complementary products

Customers who bought this product also bought:

Urine drug tests

12 in 1 multi-drugs panel dip card (Evolutive)

NCE-M12-5B
Multi-Drugs urine test (12 en 1)
In stock
1 test $19.90
5 tests $18.90 per test
10 tests $17.50 per test
20 tests $16.90 per test
View this product
FOR THE 12 MOST COMMONLY USED DRUGS CURRENTLY. This test is the most up to date with current trends in drug abuse. Its composition is constantly updated according to the latest official reports (EMCDDA, UNODC ...) and to feedback from our professional clients in the field, guaranteeing the most relevant broad screening solution.